Transcept Pharmaceuticals Inc (TSPT)

30.00
0.20 0.67
NASDAQ : Health Care
Prev Close 29.80
Open 29.60
Day Low/High 29.50 / 30.90
52 Wk Low/High 16.00 / 45.96
Volume 73.41K
Avg Volume 74.60K
Exchange NASDAQ
Shares Outstanding 19.16M
Market Cap 32.57M
EPS -1.46
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Transcept Pharmaceuticals And Paratek Pharmaceuticals Sign Merger Agreement

Transcept Pharmaceuticals And Paratek Pharmaceuticals Sign Merger Agreement

Merger to result in NASDAQ-listed biopharmaceutical company whose lead asset is a novel Phase 3-ready, oral and intravenous antibiotic drug candidate designed to address the treatment needs of patients with serious community-acquired bacterial infections.

Transcept Pharmaceuticals Announces That Largest Stockholder, Roumell Asset Management, Declares Support Of Company Strategies

Transcept Pharmaceuticals Announces That Largest Stockholder, Roumell Asset Management, Declares Support Of Company Strategies

Company also announces the appointment of Matthew M. Loar to the Transcept Board of Directors

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Transcept Sets Special Stockholders Meeting

Transcept Sets Special Stockholders Meeting

COMPANY CONTINUES TO EXPLORE STRATEGIC ALTERNATIVES

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look poised to trade higher from current levels.

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

Keep these biotech stocks on your radar.

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Commit To Buy Transcept Pharmaceuticals At $2.50, Earn 20.1% Annualized

Commit To Buy Transcept Pharmaceuticals At $2.50, Earn 20.1% Annualized

Investors eyeing a purchase of Transcept Pharmaceuticals Inc stock, but tentative about paying the going market price of $2.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2014 put at the $2.50 strike, which has a bid at the time of this writing of 30 cents.

Transcept Pharmaceuticals Comments On New FDA Dosage Reduction Requirements For Zolpidem Based Prescription Sleep Aids Administered At Bedtime

Transcept Pharmaceuticals Comments On New FDA Dosage Reduction Requirements For Zolpidem Based Prescription Sleep Aids Administered At Bedtime

FDA-mandated zolpidem dosage reduction for bedtime products such as Ambien (5 mg and 10 mg tablets) and Ambien CR (6.25 mg and 12.5 mg tablets) does not affect Intermezzo® (zolpidem tartrate 1.75 mg and 3.5 mg sublingual tablets) C-IV dosing